Development of targeted therapy in uterine serous carcinoma, a biologically aggressive variant of endometrial cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of targeted therapy in uterine serous carcinoma, a biologically aggressive variant of endometrial cancer
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 12, Issue 1, Pages 41-49
Publisher
Informa UK Limited
Online
2011-12-09
DOI
10.1586/era.11.192
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab
- (2011) P Todeschini et al. BRITISH JOURNAL OF CANCER
- Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-trop-2 monoclonal antibody
- (2011) Joyce Varughese et al. CANCER
- Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti-αV-Integrin Antibody
- (2011) Marta Bellone et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitro
- (2010) Sarah N. Cross et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma
- (2010) E Cocco et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CLEOPATRA: A Phase III Evaluation of Pertuzumab and Trastuzumab for HER2-Positive Metastatic Breast Cancer
- (2010) José Baselga et al. Clinical Breast Cancer
- Higher sensitivity to patupilone versus paclitaxel chemotherapy in primary uterine serous papillary carcinoma cell lines with high versus low HER-2/neu expression in vitro
- (2010) Daniel Paik et al. GYNECOLOGIC ONCOLOGY
- Aromatase, Cyclooxygenase 2, HER-2/neu, and P53 as Prognostic Factors in Endometrioid Endometrial Cancer
- (2010) Vincent H.W.M. Jongen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Overexpression of EpCAM in Uterine Serous Papillary Carcinoma: Implications for EpCAM-Specific Immunotherapy With Human Monoclonal Antibody Adecatumumab (MT201)
- (2010) K. El-Sahwi et al. MOLECULAR CANCER THERAPEUTICS
- Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer
- (2009) E Cocco et al. BRITISH JOURNAL OF CANCER
- In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma
- (2009) K El-Sahwi et al. BRITISH JOURNAL OF CANCER
- Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models
- (2009) W. Scheuer et al. CANCER RESEARCH
- Uterine papillary serous carcinoma: epidemiology, pathogenesis and management
- (2009) Amanda Nickles Fader et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
- (2009) Gini F. Fleming et al. GYNECOLOGIC ONCOLOGY
- Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths
- (2008) Stefanie M. Ueda et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I–II serous endometrial cancer
- (2008) Kaled M. Alektiar et al. GYNECOLOGIC ONCOLOGY
- Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu
- (2008) Alessandro D. Santin et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: A gynecologic oncology group study
- (2007) T.A. Grushko et al. GYNECOLOGIC ONCOLOGY
- HER-2/neuoverexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription-polymerase chain reaction, and fluorescencein situhybridization
- (2007) F.E ODICINO et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now